Rua Bioscience Limited

NZ$0.03As of Sun 8 Nov 2026, 12:00 UTC
NZX:RUAHealthcare
Country New Zealand
PE (Fwd) •••
TSR 6Y CAGR (39.29%)
Div yield —
ROE (73.47%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.62
PE TTM —
TSR TTM (20.94%)
Mkt cap NZ$8.825M
ROIC (33.51%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0307
17.92%
(50.76%)
Hold 1|12|7|9|3
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
2.23%
(9.61%)
(3.12%)
5.02%
Revenue$M
0.392
0.396
0.393
0.412
2.43%
2.22%
2.90%
9.33%
Peers (US$4.896M)
Cap (US$)
PE
18.98M
3.003x
17.74M
50.00x
4.921M
—
Capital
TTM
5Y
10Y
Leveragex
0.777
—
—
EBIT/Intx
0.757
0.288
0.322
Own earn%
(90.96)
75.92
72.47
Sh yield%
38.13
22.83
29.08
Owners
Insiders/Inst%
6.65
41.78
Short interest%
0.61
SBC / revenue%
4.08
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
15–24
$1 testx
0.0
Incr. ROIC%
4